{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:40:27Z","timestamp":1773279627526,"version":"3.50.1"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1097\/gme.0b013e3181dd052f","type":"journal-article","created":{"date-parts":[[2010,6,15]],"date-time":"2010-06-15T11:25:17Z","timestamp":1276601117000},"page":"1055-1063","source":"Crossref","is-referenced-by-count":25,"title":["Apigenin blocks induction of vascular endothelial growth factor mRNA and protein in progestin-treated human breast cancer cells"],"prefix":"10.1097","volume":"17","author":[{"given":"Benford","family":"Mafuvadze","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indira","family":"Benakanakere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salman M.","family":"Hyder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-28-20210227","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/jnci\/92.4.328","article-title":"Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.","volume":"92","author":"Ross","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R2-28-20210227","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1002\/cncr.20499","article-title":"Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.","volume":"101","author":"Chen","year":"2004","journal-title":"Cancer"},{"key":"R3-28-20210227","first-page":"392","article-title":"Progestin regulation of vascular endothelial growth factor in human breast cancer.","volume":"58","author":"Hyder","year":"1998","journal-title":"Cancer Res"},{"key":"R4-28-20210227","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/ijc.1236","article-title":"Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells.","volume":"92","author":"Hyder","year":"2001","journal-title":"Int J Cancer"},{"key":"R5-28-20210227","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1158\/1078-0432.CCR-06-0427","article-title":"Natural and synthetic progestins accelerated 7, 12-dimethylbenz(a)anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.","volume":"12","author":"Benakanakere","year":"2006","journal-title":"Clin Cancer Res"},{"key":"R6-28-20210227","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1093\/carcin\/17.9.2069","article-title":"Medroxyprogesterone acetate accelerates the development and increases the incidence of mouse mammary tumors induced by dimethylbenzanthracene.","volume":"17","author":"Aldaz","year":"1996","journal-title":"Carcinogenesis"},{"key":"R7-28-20210227","doi-asserted-by":"crossref","first-page":"9929","DOI":"10.1158\/0008-5472.CAN-07-1103","article-title":"Progestin-dependent progression of human breast tumor xenografts: a novel model for evaluating antitumor therapeutics.","volume":"67","author":"Liang","year":"2007","journal-title":"Cancer Res"},{"key":"R8-28-20210227","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1677\/erc.1.01221","article-title":"Vascular endothelial growth factor induces proliferation of breast cancer cells and inhibits the anti-proliferative activity of anti-hormones.","volume":"13","author":"Liang","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"R9-28-20210227","first-page":"233","article-title":"Apigenin and cancer chemoprevention: progress, potential and promise review.","volume":"30","author":"Patel","year":"2006","journal-title":"Int J Oncol"},{"key":"R10-28-20210227","first-page":"413","article-title":"Apigenin inhibits growth and induces GM\/2 arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.","volume":"21","author":"Yin","year":"2001","journal-title":"Anticancer Res"},{"key":"R11-28-20210227","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1207\/s15327914nc4801_14","article-title":"Individual and interactive effects of apigenin analogs G2\/M cell-cycle arrest in human colon carcinoma cell lines.","volume":"48","author":"Wang","year":"2004","journal-title":"Nutr Cancer"},{"key":"R12-28-20210227","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0959-8049(99)00168-9","article-title":"Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukemia HL-60 cells.","volume":"35","author":"Wang","year":"1999","journal-title":"Eur J Cancer"},{"key":"R13-28-20210227","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/mc.10168","article-title":"Molecular mechanisms for apigenin-induced cell-cycle arrest and apoptosis of hormone refractory prostate carcinoma DU145 cells.","volume":"39","author":"Shukla","year":"2004","journal-title":"Mol Carcinog"},{"key":"R14-28-20210227","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/carcin\/bgn244","article-title":"Apigenin inhibited migration and invasion of human ovarian cancer A2780 cells through focal adhesion kinase.","volume":"29","author":"Hu","year":"2008","journal-title":"Carcinogenesis"},{"key":"R15-28-20210227","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1006\/bbrc.2001.5672","article-title":"Selective growth-inhibitory, cell-cycle deregulatory and apoptotic response of apigenin in normal versus human prostate carcinoma cells.","volume":"287","author":"Gupta","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"R16-28-20210227","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0278-6915(00)00046-6","article-title":"Estrogenic activity of flavonoids in mice. The importance of estrogen receptor distribution, metabolism and bioavailability.","volume":"38","author":"Breinholt","year":"2000","journal-title":"Food Chem Toxicol"},{"key":"R17-28-20210227","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/bcr1797","article-title":"Inhibition of proteosome activity by the dietary flavonoid apigenin is associated with growth inhibition in cultured breast cancer cells and xenografts.","volume":"9","author":"Chen","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"R18-28-20210227","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/carcin\/bgl205","article-title":"Apigenin inhibits tumor angiogenesis through decreasing HIF-1 and VEGF expression.","volume":"28","author":"Fang","year":"2007","journal-title":"Carcinogenesis"},{"key":"R19-28-20210227","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jsbmb.2004.12.011","article-title":"p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.","volume":"93","author":"Liang","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R20-28-20210227","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1525-1438.2006.00696.x","article-title":"Effects of 17-estradiol, progesterone, synthetic progestins, tibolone, and raloxifene on vascular endothelial growth factor and thrombospondin-1 messenger RNA in breast cancer cells.","volume":"16","author":"Mirkin","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"R21-28-20210227","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2174\/1568009043481515","article-title":"A rationale for inhibiting progesterone-related pathways to combat breast cancer.","volume":"4","author":"Moore","year":"2004","journal-title":"Curr Cancer Drug Targets"},{"key":"R22-28-20210227","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1210\/en.2008-1630","article-title":"DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast.","volume":"150","author":"Graham","year":"2009","journal-title":"Endocrinology"},{"key":"R23-28-20210227","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/gme.0b013e3181d3dd0c","article-title":"Synthetic progestins induce growth and metastasis of BT-474 human breast cancer xenografts in nude mice.","volume":"17","author":"Liang","year":"2010","journal-title":"Menopause"},{"key":"R24-28-20210227","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/gme.0b013e31814fae5d","article-title":"Curcumin inhibits MPA-induced secretion of VEGF from T47-D human breast cancer cells.","volume":"15","author":"Carroll","year":"2008","journal-title":"Menopause"},{"key":"R25-28-20210227","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/toxsci\/kfi015","article-title":"Novel progestogenic activity of environmental endocrine disruptors in the upregulation of calbindin-D9k in an immature mouse model.","volume":"83","author":"Jung","year":"2005","journal-title":"Toxicol Sci"},{"key":"R26-28-20210227","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2008.08.021","article-title":"Detection of potential (anti)progestagenic endocrine disruptors using recombinant human progesterone receptor binding and transactivation assay.","volume":"295","author":"Viswanath","year":"2008","journal-title":"Mol Cell Endocrinol"},{"key":"R27-28-20210227","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0015-0282(02)04577-6","article-title":"Progestins activate vascular endothelial growth factor gene transcription in endometrial adenocarcinoma cells.","volume":"79","author":"Mueller","year":"2003","journal-title":"Fertil Steril"},{"key":"R28-28-20210227","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1007\/s00018-009-0017-3","article-title":"Estrogen and progesterone receptors: from molecular structures to clinical targets.","volume":"66","author":"Ellmann","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"R29-28-20210227","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1210\/mend-3-2-295","article-title":"Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists and growth factors.","volume":"3","author":"Read","year":"1989","journal-title":"Mol Endocrinol"},{"key":"R31-28-20210227","doi-asserted-by":"crossref","first-page":"20091","DOI":"10.1074\/jbc.M301410200","article-title":"Vascular endothelial growth factor-dependent downregulation of Flk-1\/KDR involves Cbl-mediated ubiquitination.","volume":"278","author":"Duval","year":"2003","journal-title":"J Biol Chem"},{"key":"R32-28-20210227","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1006\/bbrc.1998.8977","article-title":"Modulation of androgen and progesterone receptors by phytochemicals in breast cancer cell lines.","volume":"248","author":"Rosenberg","year":"1998","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00042192-201017050-00028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T01:33:03Z","timestamp":1618277583000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042192-201017050-00028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e3181dd052f","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}